Prevacid 24HR is owned by Perrigo (Ireland, NYSE: PRGO), which acquired the brand on 29 November 2019 for $61.5 million from GSK.[1][2]
Evidence: Perrigo Company plc Annual Report on Form 10-K filed 2026-02-26, SEC EDGAR, 26 February 2026. Verified from filings; last checked .
Prevacid 24HR is a lansoprazole heartburn treatment sold over the counter in the United States, one of the proton pump inhibitors that moved off prescription in the 2000s. Perrigo acquired the American rights in 2020. These drugs suppress stomach acid production rather than neutralising it, which is why they work over days rather than minutes.
A plain count of the times the name appears in the text of each annual report, not counting the start of a sentence. A brand that an owner writes about more is usually one it treats as central.
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Perrigo ownership tree →
See the full Perrigo brand portfolio (3) →
Perrigo controls 3 brands on Brandtree, 2 of them in consumer health.
The 25 brands in digestive health on Brandtree belong to 18 owners. The largest is Bayer, with 2.
| Brand | Owner | Owner based in |
|---|---|---|
| Alka-Seltzer | Bayer | 🇩🇪 Germany |
| Daiichi Sankyo Stomach Medicine | Daiichi Sankyo Healthcare | 🇯🇵 Japan |
| Kaopectate | Genomma Lab | 🇲🇽 Mexico |
| Epocler | Hypera | 🇧🇷 Brazil |
| Entrostop | Kalbe Farma | 🇮🇩 Indonesia |
| Metamucil | Procter & Gamble | 🇺🇸 United States |
| Buscolysin | Sopharma | 🇧🇬 Bulgaria |
| Oracal | Birzeit Pharmaceutical | 🇵🇸 Palestine |
Perrigo is a publicly listed company headquartered in Dublin, Ireland, founded in 1887. Brandtree records 3 brands under its control, and it is listed as NYSE: PRGO.
Perrigo was founded in Michigan in 1887 and built its business on making store-brand versions of over-the-counter medicines, so its products are sold under supermarket and pharmacy labels rather than its own name. It has more recently bought consumer brands to sit alongside that business.
Brandtree records a controlling owner for 2,549 brands that began in the United States. 478 of them (19%) are now controlled by a company headquartered in another country, Prevacid 24HR among them.
Perrigo bought the branded over-the-counter rights to Prevacid 24HR from GlaxoSmithKline for $61.5 million in cash, capitalising $61.7 million including closing costs as a brand intangible and amortising it over twenty years. What changed hands was the right to sell the brand over the counter rather than the underlying drug, which is how most of Perrigo's branded portfolio has been assembled.
The parent company of Prevacid 24HR is Perrigo, a publicly listed company headquartered in Ireland.
Prevacid 24HR originated in the United States in 2009, but it is owned today by Perrigo, which is headquartered in Ireland. So Prevacid 24HR is an American-origin brand under Irish ownership.
Perrigo completed its acquisition of Prevacid 24HR on 29 November 2019. The deal was valued at $61.5 million (enterprise value).
Yes. As of 16 September 2026, Prevacid 24HR is still owned by Perrigo. The ownership record was last checked against primary sources on that date.
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.
Brandtree needs to remember this choice and does not set any other cookie unless you accept.
If you choose “Accept all”, we also use Google Analytics cookies to count visits and see which pages help, so we can improve the site.
If you choose “Accept required”, no analytics cookie is set. Google Analytics still receives a cookieless ping with the page address and your IP address. No advertising is used either way. Privacy policy